Gladius Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-81,200
| Closed | -$9.77M | – | 78 |
|
|
2026
Q1 | $9.77M | Buy |
+81,200
| New | +$9.37M | 0.44% | 61 |
|
|
2025
Q2 | – | Sell |
-25,300
| Closed | -$2.27M | – | 74 |
|
|
2025
Q1 | $2.27M | Sell |
25,300
-16,700
| -40% | -$1.56M | 0.6% | 45 |
|
|
2024
Q4 | $4.18M | Sell |
42,000
-1,200
| -3% | -$124K | 0.45% | 38 |
|
|
2024
Q3 | $4.91M | Buy |
43,200
+26,800
| +163% | +$3.18M | 0.59% | 30 |
|
|
2024
Q2 | $2.03M | Buy |
16,400
+1,900
| +13% | +$245K | 0.25% | 49 |
|
|
2024
Q1 | $1.91M | Sell |
14,500
-19,100
| -57% | -$2.35M | 0.63% | 29 |
|
|
2023
Q4 | $3.66M | Sell |
33,600
-54,200
| -62% | -$5.63M | 0.57% | 36 |
|
|
2023
Q3 | $9.04M | Buy |
87,800
+37,100
| +73% | +$4M | 0.38% | 55 |
|
|
2023
Q2 | $5.85M | Sell |
50,700
-30,500
| -38% | -$3.46M | 0.29% | 40 |
|
|
2023
Q1 | $8.64M | Buy |
81,200
+65,200
| +408% | +$7.04M | 0.5% | 42 |
|
|
2022
Q4 | $1.78M | Sell |
16,000
-20,000
| -56% | -$2.04M | 0.13% | 47 |
|
|
2022
Q3 | $3.1M | Buy |
36,000
+18,900
| +111% | +$1.69M | 0.14% | 65 |
|
|
2022
Q2 | $1.56M | Buy |
17,100
+9,200
| +116% | +$816K | 0.08% | 79 |
|
|
2022
Q1 | $649K | Buy |
+7,900
| New | +$623K | 0.05% | 89 |
|
|
2021
Q2 | – | Sell |
-210,334
| Closed | -$15.5M | – | 159 |
|
|
2021
Q1 | $15.5M | Buy |
210,334
+36,052
| +21% | +$2.66M | 0.58% | 47 |
|
|
2020
Q4 | $13.6M | Buy |
174,282
+146,405
| +525% | +$11.2M | 0.67% | 51 |
|
|
2020
Q3 | $2.21M | Buy |
+27,877
| New | +$2.18M | 0.22% | 59 |
|
|
2020
Q2 | – | Sell |
-43,911
| Closed | -$3.22M | – | 90 |
|
|
2020
Q1 | $3.22M | Sell |
43,911
-67,282
| -61% | -$5.29M | 0.34% | 26 |
|
|
2019
Q4 | $9.65M | Sell |
111,193
-476,630
| -81% | -$39.1M | 0.61% | 35 |
|
|
2019
Q3 | $47.2M | Buy |
587,823
+173,863
| +42% | +$13.9M | 2.15% | 6 |
|
|
2019
Q2 | $33.5M | Buy |
413,960
+203,417
| +97% | +$15.6M | 1.99% | 9 |
|
|
2019
Q1 | $16.7M | Buy |
210,543
+2,620
| +1% | +$196K | 0.92% | 21 |
|
|
2018
Q4 | $15.2M | Buy |
207,923
+186,439
| +868% | +$13.2M | 0.74% | 29 |
|
|
2018
Q3 | $1.45M | Sell |
21,484
-5,240
| -20% | -$334K | 0.14% | 34 |
|
|
2018
Q2 | $1.55M | Buy |
+26,724
| New | +$1.51M | 0.16% | 41 |
|
Other funds holding MRK
Gladius Capital Management's MRK Position: Q2 2026 in Review
Gladius Capital Management sold out of Merck (MRK) in Q2 2026, closing a stake of 7,500 shares — an estimated $878K sold.
Gladius Capital Management first reported a position in MRK in Q2 2018 and held it in 23 quarters. The position peaked at $5.16M in Q3 2019. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Gladius Capital Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Gladius Capital Management sold 7,500 Merck shares in Q2 2026, an estimated $878K.
- Gladius Capital Management first reported a position in Merck in Q2 2018 and held it in 23 quarters.
- Gladius Capital Management's Merck position peaked at $5.16M in Q3 2019.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Gladius Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.